Michael Benkowitz
2017
In 2017, Michael Benkowitz earned a total compensation of $11.6M as President and Chief Operating Officer at United Therapeutics, a 116% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,043,171 |
|---|---|
| Non-Equity Incentive Plan | $738,750 |
| Option Awards | $9,017,790 |
| Salary | $733,333 |
| Other | $24,433 |
| Total | $11,557,477 |
Benkowitz received $9M in option awards, accounting for 78% of the total pay in 2017.
Benkowitz also received $1M of change in pension value and nonqualified deferred compensation earnings, $738.8K in non-equity incentive plan, $733.3K in salary and $24.4K in other compensation.
Rankings
In 2017, Michael Benkowitz's compensation ranked 487th out of 14,666 executives tracked by ExecPay. In other words, Benkowitz earned more than 96.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 487 out of 14,666 | 97th |
Division Manufacturing | 156 out of 5,772 | 97th |
Major group Chemicals And Allied Products | 37 out of 2,075 | 98th |
Industry group Drugs | 26 out of 1,731 | 99th |
Industry Pharmaceutical Preparations | 23 out of 1,333 | 98th |
Source: SEC filing on April 27, 2018.
Benkowitz's colleagues
We found three more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2017.